BioLumic has raised $US5 million ($NZ6.8m) in funding to help deal with growing global demand for increased agricultural crop yields using short-duration ultra-violet treatments rather than genetic modification or chemicals.
The Palmerston North-based company, creator of the world's first crop-yield enhancement system using UV light, attracted funding from Silicon Valley agritech investor Finistere Ventures, the Radicle Growth acceleration fund whose investors include Finistere, Rabobank's recently-launched global Food Agri Innovation Fund and existing investors from across New Zealand.
The seed treatment industry is worth an estimated $US10 billion a year and crop disease infection and insect pest damage are two of the most significant crop loss factors worldwide.
BioLumic treats seedlings and seeds and its patented technology applies UV light treatments to deliver long-term crop benefits - including improved crop consistency, increased yield and disease resistance.
"Lighting technology primes plants to thrive, not just survive; triggering long-term improvements in yield [gains were recorded at harvest, eight or more weeks after treatment], disease and pest resistance and enhance colour and flavour profiles," it said.
Initially focused on lettuce, broccoli, strawberry and tomato seedlings, BioLumic will use the $US5m to accelerate development and commercialisation of its seed-focused technology, expanding into row crop and vegetable seeds.
The investment will also be used to aggressively expand the BioLumic team in both New Zealand and its US office in California, and to intensify the global deployment of its UV technologies, it said.
Seedling trials with large-scale vegetable growers and processors in California and Mexico (UK and Spain started last May) have demonstrated yield gains of up to 22 per cent, it said.
Successful lettuce trials for California's largest salad grower resulted in an average 10 percent increased yield, and the company - Taylor Farms Mexico, a division of Taylor Farms USA - later became BioLumic's foundation client.